Top Markets
#1 Black Phoenix Black Phoenix +355.53%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +65.70%
#4 Gold Park Gold Park +62.71%
#5 OpenEden OpenEden +56.54%
#6 BasedHype BasedHype +27.42%
#7 Avantis Avantis +22.22%
#8 Cryptopia Cryptopia +21.54%
#9 Acurast Acurast +18.38%
#10 Humanity Humanity +17.96%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Aibotics Inc. Aibotics Inc.

Aibotics Inc.

AIBT
Clasificación en acciones #40326
Aibotics Inc., together with its subsidiaries, engages in the study of... Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Florida.
Precio por acción
$0.0004
Capitalización bursátil
$176.25K
Cambio (1 día)
11.11%
Cambio (1 año)
-86.67%
País
US
Comercio Aibotics Inc. (AIBT)

Categoría

Healthcare
Ratio P/B de Aibotics Inc. (AIBT)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Aibotics Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Aibotics Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.6634 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0941 -
US